Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|April 23, 2013
[Safety and technical feasibility of single-direction VATS lobectomy: a review of 1040 cases]Qiang Pu, Lin Ma, Guo-Wei Che, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 20, 2008
[Bronchial sleeve resection and reconstruction of pulmonary artery by video-assisted thoracic small incision surgery for central lung cancer: a report of 139 cases]Wen-long Shao, Lun-xu Liu, Jian-xing He, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|April 23, 2013
[Immune functions of patients following lobectomy for lung cancers: a comparative study between video-assisted thoracoscopic surgery and posterolateral thoracotomy]Qiang Pu, Lin Ma, Jian-Dong Mei, et al.
Chinese Medical Journal|November 4, 2021
Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysisCheng-Lin Guo, Jian-Dong Mei, Yu-Long Jia, et al.
Chinese Medical Journal|January 5, 2013
Perioperative and long-term outcome of thymectomy for myasthenia gravis: comparison of surgical approaches and prognostic analysisCheng-wu Liu, Meng Luo, Jian-dong Mei, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|June 16, 2017
[Diagnosis and Surgical Treatment of Lung Ground-glass Opacities:a Review of 663 Cases]Shi-You Wei, Ke-Jia Zhao, Cheng-Lin Guo, et al.
Thoracic Cancer|January 23, 2019
Lymph node metastasis in Chinese patients with clinical T1 non-small cell lung cancer: A multicenter real-world observational studyBing Chen, Xiaojun Wang, Xinnian Yu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 15, 2025
Baicalein relieves lung graft ischemia-reperfusion injury by reducing advanced glycation endproducts: From screens to mechanismsDong Tian, Xiang-Yun Zheng, Sen-Lin Hou, et al.
The Lancet. Oncology|November 28, 2017
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 studyWen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.
JTO Clinical and Research Reports|January 3, 2022
Real-World Survival Outcomes Based on <i>EGFR</i> Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN StudyXue-Ning Yang, Hong-Hong Yan, Jun Wang, et al.
Pageof 6